Transgendered Athletes

Transgender Athletes
A transgender male (FTM) athlete that has declared their identity as male may compete only in the men’s division.
A transgender female (MTF) athlete may compete in the men’s division but may only compete in the women’s division if being treated with *testosterone suppression medication (estrogen) for a minimum of one calendar year before competition and provide documentation to verify initiation of therapy.
*Research suggests that androgen deprivation through the use of hormone replacement therapy will reduce muscle mass accordingly. One year of hormone therapy is appropriate transitional time before a (MTF) athlete may compete in the women’s division. A (MTF) Athlete MUST provide documentation, established within 1 month prior to competition, that puts their Testosterone ratio level within an acceptable range for Women. The accepted range of Testosterone in a Female in the Medical Community is Between 15-70 nanograms per deciliter of blood plasma. If a lifter cannot provide acceptable documentation , then they will be placed in their naturally assigned gender.
ADDITIONAL CONSIDERATIONS:
It is the athlete’s responsibility to:
(i)    In order to avoid challenges to transgender participation at competitions, the athlete who has completed, plans to initiate, or is in the process of taking hormones as part of a gender transition must submit notice to the meet director of their intent.
(ii)     The notice must include a letter from the athlete’s physician documenting the transition status along with any prescribed hormone treatment if applicable.
It is RPS’s responsibility to:
All discussions about an individual athlete’s transgender identity and the physician’s medical documentation provided in accordance to this policy, shall be maintained confidential unless the athlete makes a specific request otherwise.